Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cilloni

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Blood|August 12, 2000
Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patientsM Tiribelli, A Tonso, D Ferrro, et al.
Bone Marrow Transplantation|April 1, 1999
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezingD Cilloni, D Garau, E Regazzi, et al.
Leukemia|April 7, 1998
Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cellsB Savoldo, G Sammarelli, G Dotti, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
British Journal of Haematology|December 21, 2000
Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantationJ Roman, A Parziale, E Gottardi, et al.
Leukemia|October 3, 2002
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsD Cilloni, E Gottardi, D De Micheli, et al.
Leukemia|June 1, 2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcriptsA Guerrasio, C Pilatrino, D De Micheli, et al.
Leukemia|October 5, 2007
The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locusS Burgstaller, S Kreil, K Waghorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Blood|August 12, 2000
Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patientsM Tiribelli, A Tonso, D Ferrro, et al.
Bone Marrow Transplantation|April 1, 1999
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezingD Cilloni, D Garau, E Regazzi, et al.
Leukemia|April 7, 1998
Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cellsB Savoldo, G Sammarelli, G Dotti, et al.
Blood|November 9, 2000
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantationD Cilloni, C Carlo-Stella, F Falzetti, et al.
Blood|May 26, 1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cellsC Carlo-Stella, E Regazzi, G Sammarelli, et al.
British Journal of Haematology|December 21, 2000
Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantationJ Roman, A Parziale, E Gottardi, et al.
Leukemia|October 3, 2002
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsD Cilloni, E Gottardi, D De Micheli, et al.
Leukemia|June 1, 2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcriptsA Guerrasio, C Pilatrino, D De Micheli, et al.
Leukemia|October 5, 2007
The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locusS Burgstaller, S Kreil, K Waghorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Pageof 4